T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$1.82B |
| 2 |
Sea Limited
SE
|
+$1.38B |
| 3 |
Cisco
CSCO
|
+$1.16B |
| 4 |
Netflix
NFLX
|
+$1.14B |
| 5 |
Ingersoll Rand
IR
|
+$1.03B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.54B |
| 2 |
Amazon
AMZN
|
+$1.75B |
| 3 |
Amphenol
APH
|
+$1.65B |
| 4 |
KLA
KLAC
|
+$1.5B |
| 5 |
Xcel Energy
XEL
|
+$1.38B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.6% |
| 2 | Financials | 11.17% |
| 3 | Healthcare | 11.1% |
| 4 | Communication Services | 10.25% |
| 5 | Consumer Discretionary | 10.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
Methode Electronics
MEI
$458M
| $335K | ﹤0.01% |
60,656
+13,134
| +28% | +$96.1K |
|
2627
Third Coast Bancshares
TCBX
$738M
| $335K | ﹤0.01% |
8,838
+1,164
| +15% | +$46K |
|
|
CBLL
2628
CeriBell Inc
CBLL
$673M
| $335K | ﹤0.01% |
18,231
+3,180
| +21% | +$63.9K |
|
2629
Microvast
MVST
$237M
| $333K | ﹤0.01% |
221,901
+28,304
| +15% | +$68.2K |
|
2630
Jack in the Box
JACK
$314M
| $331K | ﹤0.01% |
34,160
-2,668
| -7% | -$47.2K |
|
2631
Hingham Institution for Saving
HIFS
$624M
| $330K | ﹤0.01% |
1,152
+185
| +19% | +$54.1K |
|
2632
Cooper-Standard Automotive
CPS
$517M
| $329K | ﹤0.01% |
11,795
+2,061
| +21% | +$68.9K |
|
2633
Satellogic
SATL
$491M
| $328K | ﹤0.01% |
60,170
+25,591
| +74% | +$94.3K |
|
2634
ARS Pharmaceuticals
SPRY
$579M
| $328K | ﹤0.01% |
40,779
+6,991
| +21% | +$67K |
|
2635
International Money Express
IMXI
$389M
| $327K | ﹤0.01% |
20,650
+3,701
| +22% | +$57.8K |
|
|
LBRX
2636
LB Pharmaceuticals
LBRX
$1.12B
| $327K | ﹤0.01% |
13,229
+2,155
| +19% | +$49.7K |
|
|
CCRN
2637
DELISTED
Cross Country Healthcare
CCRN
| $326K | ﹤0.01% |
34,590
-1,248
| -3% | -$11.2K |
|
2638
Columbia Financial
CLBK
$1.14B
| $326K | ﹤0.01% |
18,608
+2,502
| +16% | +$43K |
|
2639
RCI Hospitality Holdings
RICK
$202M
| $326K | ﹤0.01% |
14,271
+1,472
| +12% | +$34.7K |
|
|
FPI
2640
Farmland Partners
FPI
$415M
| $325K | ﹤0.01% |
28,894
+4,566
| +19% | +$52.4K |
|
2641
Designer Brands
DBI
$315M
| $324K | ﹤0.01% |
56,887
| – | – |
|
2642
Distribution Solutions Group
DSGR
$1.6B
| $324K | ﹤0.01% |
12,316
+1,202
| +11% | +$33.6K |
|
2643
Vanguard Dividend Appreciation ETF
VIG
$111B
| $323K | ﹤0.01% |
1,500
| – | – |
|
2644
Mesa Laboratories
MLAB
$551M
| $322K | ﹤0.01% |
3,637
+496
| +16% | +$42.7K |
|
2645
Pulse Biosciences
PLSE
$2.37B
| $321K | ﹤0.01% |
14,859
+3,628
| +32% | +$67K |
|
2646
Rigel Pharmaceuticals
RIGL
$723M
| $321K | ﹤0.01% |
11,856
+1,422
| +14% | +$47.8K |
|
2647
Tiptree Inc
TIPT
$694M
| $320K | ﹤0.01% |
18,876
+5,856
| +45% | +$100K |
|
2648
Acco Brands
ACCO
$399M
| $319K | ﹤0.01% |
106,061
+10,446
| +11% | +$39.3K |
|
2649
Hyliion Holdings
HYLN
$578M
| $319K | ﹤0.01% |
181,095
+53,349
| +42% | +$107K |
|
|
JBIO
2650
Jade Biosciences
JBIO
$1.18B
| $318K | ﹤0.01% |
22,578
-2,591
| -10% | -$37.5K |
|
Similar funds
T. Rowe Price Associates's Q1 2026 Portfolio in Review
As of Q1 2026, T. Rowe Price Associates held 3,202 positions worth $865B, down 6.7% from $927B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
T. Rowe Price Associates's Q1 2026 filing shows 115 new, 2,022 increased, 804 reduced and 71 closed positions. Its largest new stake was Cenovus Energy: 23,907,299 shares worth $634M. The largest sale was Microsoft, an estimated $3.54B.
By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q1 2026 buy was Cenovus Energy: 23,907,299 shares worth $634M.
- T. Rowe Price Associates added most to Advanced Micro Devices in Q1 2026, an estimated $1.82B increase.
- T. Rowe Price Associates's biggest Q1 2026 reduction was Microsoft, cutting an estimated $3.54B.
- T. Rowe Price Associates fully exited CyberArk in Q1 2026, selling an estimated $251M.
- T. Rowe Price Associates's ten largest holdings make up 34% of its $865B portfolio in Q1 2026.
- T. Rowe Price Associates opened 115 new positions and closed 71 in Q1 2026.
- T. Rowe Price Associates's portfolio value fell 6.7% quarter-over-quarter to $865B.
Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.